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Abstract
In situ measurements are made without the removal of a physical sample and have many advantages over traditional ex situ 
measurements, made on a removed sample usually in a remote laboratory. The quality of ex situ measurements is usually 
expressed primarily in terms of their measurement uncertainty, including that arising during the sampling process. However, 
estimates of uncertainty for in situ measurement values have not usually included this uncertainty from sampling (UfS). It 
is argued that the making of an in situ measurement inevitably includes the taking of an ‘undisturbed sample’ that generates 
UfS, which should be included in the estimate of measurement uncertainty. Because undisturbed samples are not prepared or 
mixed, as is usual for removed samples, the heterogeneity of the analyte concentration in the sampling target is the primary 
source of UfS. Existing methods for estimating UfS for ex situ measurements can broadly be applied to in situ measurements. 
However, four extra challenges that limit the design and uptake of uncertainty estimation for in situ methods are identified, 
and possible solutions and actions required are discussed. Examples of in situ measurements considered include Pb in top 
soil by hand-held PXRF, 137Cs at a nuclear site by portable gamma-ray spectrometry, and bilirubin in new-born infants by 
hand-held reflectance photometry.
Keywords In situ measurement · Uncertainty · Sampling · Heterogeneity
Introduction
This paper aims to describe in situ measurements in general, 
identify the challenges there are in estimating their uncer-
tainty, and suggest possible solutions to these challenges. 
In situ measurements of chemical concentration are made at 
the original location of the test material without the removal 
of a physical sample. Such measurements are now becoming 
more prevalent than traditional ex situ measurements. In situ 
measurements cover an enormous diversity of analytes, tar-
gets and situations at a wide range of different measurement 
scales, from the macro (e.g. centimetre scale with PXRF 
[1]) down to the micro (e.g. microns with SIMS [2]), with 
the mass of the corresponding ‘undisturbed sample’ ranging 
from micrograms to picograms.
It is widely accepted that when such measurements are 
made ex situ in a laboratory, be that remote or’on site’, then 
the analytical method needs to be validated. The key metric 
of the quality of any measurement value is its uncertainty, 
which can be used to judge whether a measurement is fit for 
its intended purpose (FFP). However, this rigorous approach 
has not been widely applied to measurements that are made 
in situ, for reasons that will be discussed below. Once real-
istic estimates of uncertainty are available, it should then be 
possible to rigorously validate the methods used to make 
sufficiently reliable in situ measurements.
This paper will not be specifically discussed ‘on site’ 
measurements, where a physical sample is removed, but the 
ex situ measurement is made near the original location of 
the test material, typically in a field laboratory. This class 
of measurement is clearly intermediate between those made 
in situ and ex situ. In terms of uncertainty estimation and 
method validation, ‘on site’ measurement can usually be 
treated as an ex situ measurement. This is because the pri-
mary sample that has been removed can be prepared and 
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mixed in the field lab, so the uncertainty contribution from 
in situ heterogeneity contributes no more than it does for 
remote ex situ measurements.
In situ measurement methods
In situ methods are used in a wide range of different situa-
tions. These applications include a diverse range of analytes 
in environmental media, such as rocks, soils, waters and 
gases. They are increasingly also being used in the clini-
cal sector, often at a patient’s bedside at the ‘point of care’. 
Such measurements are also widespread in the manufac-
turing industries, often to monitor product intermediates to 
optimise productivity. In situ chemical measurements are 
closely related to the wider concept of ‘in situ testing’ [3], 
which also includes many types of physical measurement.
Even though making an in situ measurement does not 
include the removal of a physical sample, there is a test 
portion of the test material which is ‘interrogated’ during 
the in situ measurement process. This ‘undisturbed sample’ 
has physical dimensions of volume and mass, which can 
be hard to estimate and, critically, may vary greatly among 
different analytes. For example, when making simultaneous 
in situ measurements of 19 elements by PXRF on pellets 
made of powdered silicates [4], the ‘undisturbed sample’ 
was estimated to have a mass ranging between 0.001 mg and 
0.32 mg for Al and Ba respectively, for an 8 mm beam size.
Advantages of in situ measurement methods
The widespread adoption of in situ measurements largely 
arises from several inherent advantages. The measurement 
result is received promptly, virtually instantaneously, com-
pared to days or weeks for those made in a distant laboratory. 
In many circumstances, this higher speed is advantageous, 
saving lives in the clinical sector or saving money in the 
commercial and environmental sectors. Another benefit of 
this immediacy is the possibility for the experimenter to 
follow up unexpected outcomes promptly. In this case, the 
results of the first round of measurements are used to imme-
diately design and implement a second round whilst in the 
field, for example to investigate an anomaly discovered in the 
first round [5]. However, this approach should not be used to 
circumvent a systematic survey design, such as a predeter-
mined grid, by introducing subjective judgement. A further 
benefit of the immediacy of results is the ability for a large 
number of these in situ devices (e.g. sensors), to be set up 
as a sensing networks to monitor analyte variability across 
either time or space, which is not otherwise readily feasi-
ble. One example of this is the deployment of a network of 
sensors in an urban environment to measure air quality [6].
The second advantage of in situ measurements is usu-
ally their substantially lower cost. This can have the obvi-
ous benefit of lowering the cost of an entire investigation, 
but can also be used to enable the taking of many more 
‘samples’, an outcome that improves the appreciation of the 
entire area of study. For example, the lower cost of mak-
ing in situ gamma-ray spectrometry measurements of 137Cs 
at a former nuclear site enabled a more reliable survey for 
‘hot particles’ than laboratory measurements made on much 
smaller sample masses taken with large gaps between them 
[7]. As is usual, the in situ measurements have higher ana-
lytical uncertainty, owing to the shorter counting time pos-
sible in the field. However, the overall uncertainty of the 
in situ measurement values is lower than for the ex situ, 
because the UfS is lower for the in situ method due to the 
much higher mass of the ‘undisturbed’ sample than for the 
removed sample measured ex situ (discussed in more detail 
under ‘Treatment of bias’). Moreover, more ‘samples’ can be 
addressed by in situ measurement for the same expenditure, 
an important feature of surveys. It might well provide more 
information to make (say) 1000 less exact measurements 
than 100 more exact ones.
A third advantage is the ability to avoid sample prepara-
tion. For instance, the loss of some volatile analytes can 
occur by just removing the sample needed for laboratory 
measurement. The delay before a laboratory measurement 
can also cause further losses (e.g. of dissolved oxygen from 
water). Many of the traditional steps of sample prepara-
tion (drying, disaggregation, sieving, mixing, splitting and 
grinding of soils) can all cause further losses of analyte and 
also provide potential for contamination of the test material. 
Furthermore, some of these mechanical preparation steps 
can bias the analyte concentration. For example, sieving a 
soil at a 2-mm mesh size conforms to a widely used defi-
nition of ‘soil’ [8], but excludes larger particles and biota 
that would be included in an undisturbed sample. A closely 
related advantage is that they do not require a physical sam-
ple. That has the benefit of eliminating the costs of taking, 
storing and disposing of samples, which can be substantial 
in some sectors, such as the nuclear industry.
A fourth broad advantage of in situ measurements is that 
they can have the ability to quantify the heterogeneity of the 
test material, which provides extra valuable information not 
usually available to environmental scientists [9].
A supposed ‘advantage’, but really a disadvantage, of 
in situ measurements is that they can apparently be made 
by less skilled personnel than required for laboratory meas-
urements. The person operating, or installing, the in situ 
measurement equipment actually needs to be more highly 
trained than is required in the laboratory. In situ measure-
ment scientists need to be able to take the most appropriate 
samples (of the ‘undisturbed’ kind) in the real world, as well 
as taking measurements of acceptable quality, both without 
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local supervision. Disturbingly, because the quality of in situ 
measurements is not usually assessed rigorously, it is cur-
rently possible to use less skilled personnel without their 
adverse effects on data quality being detected.
Approaches to ensuring the quality 
of measurements, ex situ and in situ
Techniques for quantifying and improving the quality of 
ex situ measurements have been developed and well doc-
umented over the last 60 years. The most important and 
universal measure of data quality has proved to be the 
uncertainty. Informally, measurement uncertainty can be 
described as ‘the range of values within which the true 
value is asserted to lie’. Formally, measurement uncertainty 
is defined as a ‘parameter, associated with the result of a 
measurement, that characterises the dispersion of the val-
ues that could reasonably be attributed to the measurand’ 
[10]. The ‘measurand’ is formally defined as ‘the quality 
quantity intended to be measured’, but is closely related to 
the traditional concept of ‘true value’ in statistical terminol-
ogy, used for clarity in the informal definition. Uncertainty 
estimates, therefore, have both random and systematic com-
ponents, usually quantified as some form of precision and 
bias, respectively. The procedures for estimating the meas-
urement uncertainty that arises in the chemical laboratory 
are well established [11]. However, it has been recognised 
that the measurement process usually begins at the time that 
the primary sample is taken. Further guidance has therefore 
been made available on how to estimate the measurement 
uncertainty that includes that which arises from the sam-
pling process [12]. The main method that has been adopted 
to estimate the random component of the uncertainty from 
sampling (UfS) is the duplicate method. In this method, 
duplicate samples are taken at a small proportion of the 
sampling targets (e.g. 10 %, but no less than 8), selected at 
random to give a typical estimate of the UfS for all com-
parable sampling targets. Both duplicated samples are also 
chemically analysed in duplicate, in a balanced design. The 
resultant measurement results (typically 32 = 8×2×2) are 
evaluated statistically using analysis of variance (ANOVA) 
to give estimates of the measurement uncertainty, and its 
two components arising from the sampling (UfS) and the 
chemical analysis.
Guidance on the validation of ex situ methods of chemical 
analysis, largely based upon the estimates of measurement 
uncertainty, has also been agreed internationally [13]. This 
guidance does not, however, include the wider definition of 
the measurement process to include the primary sampling 
step. Because the process of in situ measurement inherently 
includes the act of selecting and taking an ‘undisturbed 
sample’, then the uncertainty of an in situ result has also to 
include uncertainty arising from sampling.
Ensuring the quality of in situ measurements
Despite the widespread adoption of in situ measurement 
methods, there is no agreement on how to ensure the quality 
of their measurement results. Measurement quality is con-
sidered even more important for in situ methods than for 
laboratory methods, because of the general lack of quality 
assurance and control (QA & QC), supervision and opera-
tor training in most fields of application. When important 
decisions are being made on the basis of in situ measure-
ments, it is particularly important that a rigorous approach 
is devised for estimating measurement uncertainty. This will 
enable both the results to be interpreted probabilistically, 
hence more reliably, and also to allow in situ methods to be 
rigorously validated.
Currently, there is no universally agreed method for 
uncertainty estimation, and hence for validation, of meth-
ods of in situ measurement. Because of this absence, other 
approaches have been applied, often tending to be specific to 
a particular application sector. A general approach is often 
referred to as ‘Type testing’ by the manufacturers of the 
measurement equipment. Type testing has been defined in 
one sector as a ‘test performed to provide evidence that the 
design meets the requirements of the functional specifica-
tion’ [14]. This ‘functional specification’ is defined as the 
‘features, characteristics, process conditions, boundaries, 
and exclusions defining the performance of the tools’ [15]. 
One common physical example of the use of type testing is 
to the equipment used to measure the electricity consumed 
in a house. Once this sealed electricity meter is installed in a 
house, it is assumed that the results of the original test (usu-
ally carried out in the place of manufacture) are applicable to 
all of the subsequent measurements made over many years. 
The potential application of type testing to in situ chemical 
measurement is problematic in many respects. The analytes 
and the test materials are more diverse and the operating 
conditions are usually more variable and potentially dam-
aging to the equipment. These conditions frequently lead 
to drift in the equipment’s performance over time. Further-
more, type testing ignores the UfS due to heterogeneity of 
the analyte in the undisturbed sample.
There are several potential reasons why uncertainty esti-
mation (and hence rigorous validation) of in situ measure-
ment methods has not been widely undertaken. One reason 
includes the great diversity in the types of in situ methods, 
and the range of different application sectors, and hence 
physical situations, in which they are applied. For example, 
in the clinical sector there is not yet a wide acceptance of 
the concept of measurement uncertainty. Any approach to 
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method validation that relies upon the estimation of meas-
urement uncertainty will currently not be readily understood 
or accepted, therefore, by front-line health care practition-
ers. A further reason is the widespread description of in situ 
measurement methods using terms such as ‘semiquantita-
tive’, ‘rough and ready’, ‘screening’ or ‘indicative’. It is 
tacitly assumed that such methods do not require rigorous 
validation. A further impediment is the difficulty in assess-
ing the validity of a method in the actual ‘field’ situation of 
application, as opposed to the place of manufacture. Ironi-
cally, the very absence across all application sectors of a 
widely accepted approach to uncertainty estimation, and 
thence validation, is the principal reason for not applying it.
One popular alternative option is the ‘validation’ of 
in situ measurement instrument by the manufacturer, usually 
in isolation and without a realistic sampling target. This can 
be done entirely on the manufacturer’s property, usually not 
in a ‘real world’ situation with a heterogeneous target, in an 
approach similar to the ‘type testing’ already discussed. The 
first limitation is that this approach can ignore the instru-
mental ‘drift’ that typically arises in the days, weeks and 
years after the manufacturer’s validation. Some manufactur-
ers do address this by providing ‘check samples’ (or better, 
certified reference materials, CRMs) to monitor instrumental 
drift on a daily or hourly basis [16]. The use of CRMs to 
monitor and subsequently correct measurement made in situ 
has been recommended by some regulators [17]. One prob-
lem with this approach is that CRMs and check samples are 
often very different from the test material in the real world. 
For example, soil CRMs are often dry, finally ground, very 
homogeneous and often compacted into pellets with very 
little pore space or extraneous matter (e.g. biota in soil). By 
contrast, soils in the real world are usually moist, extremely 
variable in grain size, very heterogeneous and contain a high 
proportion of pore space and organic matter such as plant 
roots and animals. The systematic error (or measurement 
bias) that can occur from such causes can be revealed and 
quantified by comparing in situ measurements against ex situ 
measurements made by a different analytical method on the 
same sampling targets for the same measurand, as explained 
below. The heterogeneity of the analyte in the test portion 
for ex situ measurements is usually reduced to a minimum 
by grinding and mixing. In situ, however, this heterogeneity 
is often the biggest source of uncertainty, although it is usu-
ally ignored in procedures for both uncertainty estimation 
and validation.
Estimation of U for in situ measurements
There have been several publications describing possible 
approaches to estimating the uncertainty of in situ measure-
ments, usually for the purpose of validation. These include 
studies of metals in soil [1], bilirubin in infants [18], pas-
sive detection of 137Cs by gamma-ray spectrometry [7] and 
oxygen isotope ratios in quartz by SIMS [2]. These studies 
will not be described in detail here, but only those aspects 
that illustrate general issues and help explain the outstanding 
challenges that need to be addressed.
The random components of the uncertainty of in situ 
measurements are usually estimated using the duplicate 
method, which has been widely employed for ex situ meas-
urements, as already explained. The equivalent of the ‘dupli-
cate samples’ is taken by placing the in situ measurement 
device twice, reflecting independent interpretations of the 
measurement protocol. For example, in the use of PXRF 
to measure Pb in topsoil [1] the instrument is placed on the 
soil at two estimates of the sampling location for a particular 
sampling target, separated by a distance representing the 
spatial uncertainty of the survey technique. In this example, 
the spatial uncertainty was ± 2 m, so the duplicate sample 
was located 2 m away from the first in a randomly chosen 
direction. These two sampling points are both equally likely 
interpretations of the protocol, given that particular survey-
ing technology. The duplicate in situ readings will reflect the 
effect of the small-scale spatial heterogeneity, of the analyte 
concentration at that location, on the uncertainty. The use 
of at least eight such duplicate samples, selected at random 
across the investigation site, will reflect the typical measure-
ment uncertainty caused by heterogeneity. When sampling 
in the temporal domain, for example for river waters, the 
investigator should take the duplicate samples with a time-
lapse that similarly reflects the temporal ambiguity in the 
sampling protocol.
The measurement uncertainty estimated using the dupli-
cate method alone does not include the systematic compo-
nent arising from any bias in the chemical analysis or the 
field sampling. The bias from the chemical analysis alone 
is routinely estimated typically by measurements made on 
matrix-matched CRMs and can easily be included in the 
estimate of the measurement uncertainty (see Example A2, 
p 50 in [12]). The bias generated in the sampling process has 
proved much more difficult to evaluate and to consider in 
the uncertainty estimate. The approach most often adopted 
to estimate systematic sampling effects within in situ meas-
urements, is to compare them against ex situ measurements 
made for the same measurand, on the same sampling targets. 
For the determination of Pb in top soil, take-away samples 
can be extracted at the locations where PXRF measurement 
was made and then prepared and analysed in a remote labo-
ratory [1, 19]. The bias is then estimated as a function of 
concentration, typically by ordinary regression or, prefer-
ably, FREML (functional relationship estimation by maxi-
mum likelihood [20]), a technique in which the uncertainty 
of both variables is properly taken into account. Assum-
ing no lack-of-fit, the slope of the linear model gives the 
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rotational component of the bias, and the intercept gives 
the translational component. An example of such a linear 
relationship for the Pb concentration [Pb] in top soil example 
(Fig. 1 in log space, where model appears non-linear) has 
an equation of
This equation gives an estimated rotational bias of − 57 % 
(± 8 %) (100×(1 − 0.43)) of the in situ measurements by 
PXRF compared with ex situ measurements by AAS. Pos-
sible causes of the measurement bias were identified as soil 
moisture, material > 2 mm, surface roughness in the PXRF 
‘undisturbed sample,’ and the difference in depth between 
the undisturbed sample for in situ PXRF (~ 1 mm) and the 
removed ex situ field sample for AAS (150 mm).
Challenges in uncertainty estimation 
for in situ measurements
Treatment of bias between in situ and ex situ 
measurements
One challenge is to decide what to do with this broader esti-
mate of the measurement bias, including sampling bias. The 
most frequent action is to ‘correct’ the in situ measurements 
(using a regression-type model) to agree with the ex situ 
measurements. This procedure has been recommended in 
the environmental sector [17]. In this approach, it is also 
(1)In situ [Pb] = 0.43(±0.08) × Ex situ [Pb] + 77(±26)
possible to include the uncertainty of the estimated bias 
(e.g.,  ± 8 %) into the estimate of the uncertainty of the cor-
rected measurement value. One possible criticism of this 
approach is the implicit assumption that the ex situ measure-
ments are closer to the true value of the analyte concentra-
tion (i.e., value of the measurand) [21]. In the other case 
study already discussed, (137Cs in soils), the in situ gamma-
ray measurements were shown to have a seven times lower 
uncertainty than the ex situ gamma-ray measurements [7]. 
This was primarily because the passive in situ measurements 
were based on a much larger mass of the undisturbed sample, 
estimated to be 150 kg compared to the 0.5 kg samples taken 
to the laboratory. In this case, therefore, it could be argued 
that the in situ measurements were more representative of 
the sampling targets, and therefore the ex situ measurement 
should be ‘corrected’ to agree with the in situ measurements. 
In this particular example, no significant bias was detected 
between the two sets of measurements, although this may be 
primarily due to the large uncertainty of the ex situ measure-
ments (73 %).
An alternative approach to this issue is to not ‘correct’ 
either set of measurements, but only to include any pos-
sible systematic effects into the estimate of the uncertainty 
of each measurement. In the instance of 137Cs, the large ex 
situ measurement uncertainty (U = 73 %) caused by the low 
mass of the primary sample (0.5 kg) tells us that the true 
value may be much further away from the measured value 
than observed for the in situ measurements (U = 13 %). From 
a purely metrological point of view, this method of compari-
son could be criticised because the ‘test portion’ masses are 
not matched. However, both types of sample are intended 
to represent to same sampling target, which is defined as 
a ‘portion of material, at a particular time, that the sample 
in intended to represent’ [10]. In this example, the mass of 
the sampling target was matched in both cases, because the 
samples and measurement were taken on the same sampling 
grid for the same purpose. Both the in situ and the ex situ 
sample at the location were, therefore, intended to represent 
the same sampling target, which was centred on the same 
point on the sampling grid.
Selection of reference or ex situ method to estimate 
bias
The second challenge is finding a suitable measurement 
method (e.g. ex situ) against which to estimate measurement 
bias. This can be illustrated using an example from the clini-
cal sector, namely the measurement of transcutaneous biliru-
bin (TcB) in the tissue of the new-born infant, which can be 
used to decide whether the infant needs treatment for jaun-
dice [18]. In this procedure, a hand-held reflectance photom-
eter is placed on infant’s forehead in three places to make a 
composite measurement of absorbance at 450–550 nm. The 
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Fig. 1  Systematic component of uncertainty, or ‘measurement bias’, 
between in situ and ex situ measurements of Pb concentration (black 
circles) at 35 matching locations of top soil from one site, estimated 
using a linear FREML model (red squares Eq.  1), fitted to original 
data from [19]
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result is used to decide whether a more invasive blood sam-
ple need be taken from the heel of the infant, and an ex situ 
measurement made of the total serum bilirubin (TSB). The 
ex situ TSB measurements are made using direct absorbance 
spectrophotometry at 455 nm on centrifuged blood samples 
and can also be used to estimate the bias. Interestingly, the 
potential heterogeneity of the optical density in the baby’s 
skin is implicitly recognised by the use of the three-fold 
composite to reduce its effect. On site checking for drift 
in the reflectance photometer calibration is made using a 
‘checker plate’ with two inspecting screens, one white and 
the other yellow. For TSB the random component of the 
uncertainty, here called within-run precision, was estimated 
by using fivefold replicated measurements. The estimated 
coefficient of variation varied from 0.5 to 0.9 % as the con-
centration of TSB increased. However, the more important 
precision estimates for the TcB measurements themselves 
were not reported for unexplained reasons. The systematic 
component of the uncertainty of this in situ method, called 
accuracy by these authors, was estimated by comparing the 
in situ TcB measurements against ex situ TSB measurements 
made on the same matching 271 infants (Fig. 2). The model 
of the relationship, between the two methods, made using 
Deming regression, gave the equation:
(Note: Deming regression is similar to FREML but based 
on least-squares estimation.)
No significant bias was detected between the two meth-
ods, because the slope coefficient did not differ signifi-
cantly from unity (95 % CI 0.87 to 1.16) and the intercept 
TcB = −5.5012 + 1.0160 TSB.
coefficient did not differ significantly from zero (95 % CI 
−39.71 to 28.71). Despite no detection of significant bias, 
the authors reported that ‘TcB…tended to underestimate 
the TSB, but measurements of TcB could underestimate or 
overestimate TSB values at both low and high bilirubin lev-
els.’ This comment suggests a nonlinear relationship, and 
hence use of an inappropriate linear regression model. This 
may be one reason that the authors recommended that dif-
ferent threshold values be used as the upper safe limit for 
TcB measurements (222 μmol/L) compared to that for TSB 
measurements (291 μmol/L).
The generally accepted approach of measuring CRMs to 
validate either the TcB or the TSB methods was not used, 
for unexplained reasons. This approach would have been 
useful, for example in choosing between several different 
ex situ methods, which the authors report as not even being 
consistent between themselves. The concept of measurement 
uncertainty would have allowed the inclusion of both the 
systematic and random components in all of the measure-
ments, and hence a more rigorous comparison and validation 
of both the in situ and the ex situ methods.
It is interesting that there was not a perfect match between 
the measurands specified for the two methods. This appears 
to be a potential problem for in situ measurements in gen-
eral. The effective measurand for the TSB method was the 
intravascular bilirubin concentration, while for the TcB it 
was the extravascular bilirubin concentration. The authors 
state, therefore, that the ‘TcB should not be expected to 
equal the TSB when comparing the two bilirubin measure-
ment methods’. One possible approach in this example is to 
consider the in situ TcB measurements as merely proxies 
Fig. 2  Fitted line show-
ing regression model of the 
relationship between in situ 
measurements of transcutaneous 
bilirubin (TcB) against ex situ 
measurements of total serum 
bilirubin (TSB) on 271 infants. 
(Taken from [18] with permis-
sion of Elsevier)
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for the ex situ TSB measurements upon which the clinical 
decisions are then made. However, measurements from both 
methods seem to be used for clinical decisions. In terms 
of matching the sampling targets, it could be specified as 
matching for both methods, as ‘the particular infant that may 
have jaundice’. However, at the more specific level, the target 
differs, and the main clinical diagnosis is largely based upon 
the bilirubin concentration in the serum (TSB), whilst the 
in situ TcB device measures the bilirubin in the tissue (i.e. 
skin). The sampling media between the two methods are 
evidently not matched, even though the broader sampling 
targets are.
For comparison, a very similar but independent study of 
TcB versus TSB [22], also reported evidence of some non-
correspondence between the two sets of measurements, with 
measured TcB generally greater than TSB at low values of 
TSB, and less than TSB at high values of TSB (i.e. > 16 mg/
dl). Again, the precision of the TcB measurements was 
not reported, and CRMs were not used to estimate bias or 
traceability.
This example shows that finding a matched method 
to estimate the systematic component of the uncertainty 
of in situ measurements cannot always be achieved per-
fectly. One solution would be to explain, with the reported 
uncertainty value in the validation, the degree to which the 
measurand and the sampling target of the two methods are 
matched.
Adequate staff training and supervision
The third general challenge for in situ methods is the need 
for adequate education, training and supervision. At a fun-
damental level, there needs to be an understanding of the 
concept of measurement uncertainty in all of the different 
application sectors and by all practitioners. For example, 
in the clinical sector the focus is still on the precision and 
bias of analytical methods, rather than uncertainty of the 
resultant measurement values. At the level of the operator 
of the in situ measurement device, training and supervision 
is also a key challenge. In the specific bilirubin example, it 
was noted that there was a worse correlation between TcB 
and TSB measurements when the infants were measured 
as outpatients rather than as inpatients [18]. This provides 
evidence for the need for appropriate training of the opera-
tors, particularly when they make the measurements away 
from the more supervised environment of the laboratory (or 
hospital). As noted previously, the apparent ease with which 
many in situ measurements can be made belies the higher 
level of skill and training that is required to make reliable 
measurements ‘in the field’ (e.g. at the point of care), than 
in the laboratory with its more embedded QC and QA sys-
tems. Tools to assess the quality of in situ measurements, 
and hence effectiveness of the training, are already being 
applied in some sectors. These tools include internal qual-
ity control (IQC), in which the operator routinely monitors 
the ongoing quality of the in situ measurements using both 
CRMs (or check materials) and a small proportion of dupli-
cated measurements. An even more powerful tool is to par-
ticipate in External Quality Assurance procedures (EQA), 
such as proficiency testing (PT), which has already been 
implemented for in situ stack gas emission measurements 
[23]. The PT results can not only demonstrate the quality 
that operators achieved in routine operation, but also pro-
vide feedback to the operators and their supervisors of their 
performance and the benefits of training. Adoption of these 
QC/QA tools is needed urgently for in situ measurements, 
because of the greater skill and training needed, and lack of 
supervision, in the difficult locations where most operators 
often work.
General applicability of the uncertainty estimates
The fourth challenge for in situ methods is to test the appli-
cability of reported uncertainty estimates. Clearly the effect 
of the analyte heterogeneity in the sampling target needs to 
be included in estimate of the uncertainty of measurements 
made by the in situ device. If the level of heterogeneity is 
similar for most sampling targets, then it can be assumed 
that the uncertainty estimate made at the time of validation 
will be broadly applicable for all targets. In the bilirubin 
example, if the variability of TcB within all young infants’ 
foreheads is reasonably constant, then the uncertainty esti-
mate made at the time of validation will be broadly appli-
cable. Traditional quality control practice would then be to 
routinely duplicate a small proportion of routine TcB trip-
licate measurements (e.g. 10 %, with a second set of three 
new measurement points per infant). A control chart could 
then be used to monitor whether the general level of TcB 
variability conforms to that found during the initial valida-
tion. By contrast, for the example of Pb in topsoil, the Pb 
concentration (as mass fraction) can vary widely from 10 
to 30000 mg/kg and the heterogeneity (quantified as UHET 
using the same in situ method) can also vary widely. When 
heterogeneity is expressed as relative expanded uncertainty 
of UHET, it is very variable between sites, ranging from 1 to 
100 % [9]. Across twelve different sites, heterogeneity was 
not found to increase as a function of Pb concentration, but 
rather as a function of spatial scale within some of the sites. 
In this situation, an estimate of measurement uncertainty for 
Pb concentration in soil by PXRF made at one site would 
not necessarily be applicable to such measurements made 
on soils at another sites.
Three options for overcoming this fourth challenge are 
possible. For ex situ measurements made in the laboratory, 
methods are validated for a limited range of composition. 
For example, an ICP-AES calibration might be designed and 
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validated for lightly contaminated loamy soils (composed 
mainly of silicate minerals, with Pb < 500 mg/kg) but this 
validation would not be applicable to measurements made 
on soils that have extremely different overall composition 
(e.g. very calcareous, where Ca causes substantial matrix 
effects on many analytes), or heavily contaminated with 
Pb > 5000 mg/kg. Similarly, for in situ measurements of 
Pb in soil, an uncertainty estimates made at this validation 
site would not automatically be considered applicable to all 
sites. Validation (and uncertainty estimates) would need 
to be quoted for test materials within a specified range of 
chemical composition.
A second option would be to use a general model of UfS 
(expressed as  ssam) versus analyte concentration (c) to pre-
dict the UfS, and hence the overall measurement uncertainty. 
Such a model has been described in the food sector in a 
meta-analysis of results for 75 analytes in 27 types of food, 
from field, store, factory to retail outlets [24]. The relation-
ship discovered is shown as a power law in Fig. 3, and the 
equation of the fitted model was:
Predictions from this model have relatively large con-
fidence interval, as the residual standard deviation was 
0.46, so the factor applying to predicted  ssam is  100.462 x2, 
which is almost an order of magnitude. However, the 
model might still make a useful initial estimate of UfS, 
and hence of measurement uncertainty. Most of the case 
studies used in the meta-analysis used traditional ex situ 
sampling and measurement, so the validity of the model 
s
sam
= 0.0128c0.8099.
for in situ measurements, with their ‘undisturbed’ samples, 
would need to be separately tested. Such studies need to 
be repeated, with both in situ and ex situ measurements, 
and also in other application sectors (such as soils, waters 
and gases). The first reason for this further meta-analysis 
is to be able to test whether the equation found in the food 
sector has broader applicability (rather like the Horwitz 
function for different analytical systems, Fig. 3). Secondly, 
equations in each different sector, even if dissimilar, could 
be used to make initial estimates of UfS and measurement 
uncertainty (e.g. for regulators) in particular application 
sectors.
The third option would be to treat the two main sources 
of uncertainty separately. The measurement uncertainty 
estimate for the instrument (Uinst) could be estimated in 
isolation, as is often done currently, with an effectively 
homogeneous test material. The uncertainty due to the 
heterogeneity of the analyte within the sampling target 
(UHET, equivalent to UfS), as specified in the measurement 
protocol for that test material, would need to be estimated 
as a separate objective. This could be achieved using the 
duplicate method, applying the same in situ measurement 
device, on an appropriate number of sampling targets (e.g. 
at least 8), that are typical of that applications sector. The 
two components of the uncertainty could then be com-
bined together to give an estimate of the measurement 
uncertainty using the equation:
If the range of concentration was relatively small and 
well above the detection limit, then this equation might 
be sufficient. However, if the range was large and in close 
proximity to the detection limit, then the summation would 
have to express U as a function of concentration for all 
three terms in the equation. Alternatively, a hybrid option 
could be to use predictions of UfS of in situ measurements 
from the meta-analysis model (from Option 2) for the ini-
tial estimate of UHET in Option 3.
For test materials where misclassification would have 
high financial consequences, it may be worthwhile to make 
an estimate of UHET that is specific to that site, say with at 
least 8 duplicated samples taken across the site. Balancing 
the measurement uncertainty against the cost of misclas-
sification caused by excessive uncertainty can be made 
using the optimised uncertainty procedure [1].
Similarly, as part of IQC for the bilirubin example, a 
small proportion of duplicated threefold measurements of 
TcB could be made on the forehead of randomly selected 
infants, to check whether they have a significantly higher 
level of analyte heterogeneity (as UHET and hence UfS) 
than the value assumed in the model.
U
meas
=
√
U
2
inst
+ U2
HET
Fig. 3  The linear relationship between the logarithms of the uncer-
tainty from sampling (expressed as  ssam) and the analyte concentra-
tion (c), based upon a meta-analysis across the food sector, compared 
to the Horwitz function  (RSDHor). (Reproduced from [24] with per-
mission from The Royal Society of Chemistry)
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Action required
To agree a universally applicable procedure to estimate the 
uncertainty of in situ measurements, there needs to be a 
meeting of experts from a wide range of application areas. 
This agreed procedure could then be used as the bases for 
a second universally accepted procedure for the valida-
tion for these methods. A third requirement is to agree the 
quality control procedures needed to assess the quality of 
the routine in situ measurements, when they are made by 
operators in the real world with all of its limitations of 
time and resources.
Conclusions
Chemical measurements made in situ have many advan-
tages over those made in a remote laboratory, but they 
do tend to have higher levels of measurement uncertainty 
even when conducted competently. An estimate of this 
uncertainty needs to be made in order to make sure that 
the in situ measurement results are fit-for-purpose (FFP), 
and hence to make a reliable interpretation of the results. 
The main problem lies in ensuring that the measurements 
are indeed conducted competently.
Both ex situ and in situ measurement processes include 
the sampling step, but for in situ measurements sampling 
per se is often not recognised, as the ‘undisturbed sample’ 
is usually left in place and is of unknown dimensions. 
Estimates of the uncertainty of in situ measurement values 
should never be based solely upon the instrumental repeat-
ability, as this will always lead to an underestimation. The 
heterogeneity of the analyte concentration within the sam-
pling target, and also within the undisturbed sample taken 
to represent it, causes extra uncertainty in the measure-
ment value. This is effectively the same concept as the 
uncertainty from sampling (UfS) that is associated with 
taking a physical primary sample for traditional labora-
tory measurement. Validation of all analytical procedures 
needs to use realistic estimates of measurement uncer-
tainty. These estimates need to include UfS, particularly 
for in situ measurements where the sampling step is often 
not recognised. Four main challenges for estimating the 
uncertainty of in situ measurements have been identified, 
and some possible solutions described: (1) treatment of 
bias between in situ and ex situ measurements, (2) selec-
tion of a reference or ex situ method to estimate bias (3) 
adequate training and supervision, and (4) generally appli-
cable uncertainty estimates.
Further consultation and discussions are urgently 
required between specialists from the many different 
sectors where in situ methods are applied, to agree three 
universal procedures for in situ measurements, to (1) esti-
mate the uncertainty (2) validated the methods, and (3) 
implement quality control to monitor in situ measurement 
quality in routine operation.
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